Profile
ALVO ZTS TAK HLN TEVA VTRS
Company Name Alvotech Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $3.53B $83.13B $46.98B $46.45B $21.38B $14.42B
Employees 1.00K 14.10K 49.28K 25.41K 35.00K 33.00K
CEO Mr. Robert Wessman Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Mr. Scott Andrew Smith
Ratings
ALVO ZTS TAK HLN TEVA VTRS
Quant Rating Score 2 3 4 3 1 2
Quant Rating Sell Neutral Buy Neutral Strong Sell Sell
Trading
ALVO ZTS TAK HLN TEVA VTRS
Last Close $11.68 $183.49 $14.89 $10.18 $18.87 $12.08
High 52 $17.27 $200.09 $16.32 $10.17 $18.87 $13.53
Low 52 $8.56 $145.54 $12.6 $7.78 $8.12 $8.77
Price vs. 52 Week High -32.37 % -8.3 % -8.76 % 0.1 % 0 % -10.72 %
Price vs. 52 Week Low 36.45 % 26.08 % 18.17 % 30.85 % 132.39 % 37.74 %
Total Return
ALVO ZTS TAK HLN TEVA VTRS
1 Month Return -0.17 % 1.92 % 7.28 % 11.26 % 8.26 % 0.17 %
3 Month Return -15.85 % 8.22 % 11.54 % 20.62 % 11.46 % 13.96 %
6 Month Return -25.89 % -3.84 % 2.27 % 20.47 % 39.78 % -4.05 %
9 Month Return 23.47 % 2.43 % 5.12 % 18.65 % 94.34 % 28.92 %
YTD Return 1.74 % -7.03 % 4.34 % 23.69 % 80.75 % 11.54 %
1 Year Return 17.98 % -3.68 % -3.31 % 24 % 93.34 % 12.37 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVO ZTS TAK HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 0.91 % 3.77 % 2.03 % - 3.97 %
Dividend Paid and Capex Coverage Ration (TTM) -9.45 % 2.01 % 1.21 % - 3.64 % 2.31 %
Dividend Per Share (TTM) - 1.67 % 0.56 % 0.16 % - 0.48 %
Payout Ratio (TTM) - 31.57 % 196.47 % - - -89.13 %
Growth
ALVO ZTS TAK HLN TEVA VTRS
Asset Growth 14.68 % -4.28 % 8.25 % -2.18 % -1.2 % -4.67 %
Gross Profit Growth -466.65 % 3.7 % -16.6 % 5.85 % 9.64 % 1.09 %
Revenue Growth 10.12 % 5.74 % 5.87 % 4.09 % 6.16 % -5.42 %
Revenue 3 Year -81.13 % 31.98 % 33.13 % 13.9 % -6.92 % -35.51 %
Revenue 5 Year 207.13 % 53.64 % 149.89 % 32.87 % -23.33 % -42.34 %
Revenue 10 Year 207.13 % 103.1 % 154.38 % 32.87 % -40.82 % -28.91 %
EBIT Growth -2.43 % 6.27 % 7.34 % 37.26 % -84.52 % 390.23 %
Net Income Growth -7.43 % 10.88 % -54.56 % -1.04 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 55.38 % 47.55 % -61.74 % -8.67 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share -181.85 % 71.94 % 62.27 % 59.66 % 76.28 % -93.35 %
Net Income 10 Yeari Growth Per Share -181.85 % 404.24 % 36.33 % 59.66 % -133.42 % -97.2 %
Operating Income Growth -2.43 % 6.27 % 7.34 % 37.26 % -84.52 % 390.23 %
Operating Cash Flow Growth (CFG) 0.07 % 23.06 % -34.47 % -16.48 % -13.96 % -5.18 %
Operating 3 Year CFG 42.22 % 14.12 % -36.76 % 22.08 % 10.09 % 13.84 %
Operating 5 Year CFG -277.99 % 37.69 % 139.61 % 118.54 % -48.98 % -48.75 %
Operating 10 Year CFG -277.99 % 274.61 % 335.67 % 118.54 % -67.94 % -19.21 %
EPS Growth 6.54 % 12.64 % -54.92 % - 76.42 % -97.33 %
EPS Diluted Growth 6.54 % 12.92 % -54.86 % - 76.42 % -97.35 %
Book Value Per Share -43.74 % 15.34 % 13.54 % 1.38 % -5.72 % -1.92 %
Share Holder 3 Year Equity Growth Per Share 85.21 % 36.7 % 40.38 % -36.6 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share - 139.55 % 73.27 % -39.41 % -53.44 % -27.89 %
Share Holder 10 Year Equity Growth Per Share - 476.36 % 197.1 % -39.41 % -74.76 % 122.18 %
Dividend Per Share Growth - 15.15 % 1.95 % -85.58 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % 1.19 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % 146.94 % -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 103.93 % -66.42 % -100 % -
Debt Growth 33.58 % -15.91 % 24.67 % -9.43 % -6.53 % -4.64 %
Free Cash Flow Growth 0.76 % 22.25 % -53.54 % -20.06 % -19.19 % -7.35 %
Updated On 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
ALVO ZTS TAK HLN TEVA VTRS
Gross Profit Margin TTM -15.34 % 68.75 % 62.49 % 59.91 % 49.52 % 41.22 %
Return on Assets TTM -57.87 % 16.55 % 0.92 % 3.26 % -1.15 % -1.43 %
Return on Equity TTM 86.54 % 46.65 % 2.08 % 6.54 % -6.77 % -3.2 %
Return on Capital Employed TTM 217.97 % 26.29 % 3.36 % 7.25 % 9 % 3.69 %
Net Income Per EBT TTM 93.31 % 81 % 292.06 % 65.38 % 287.88 % 101.02 %
EBT Per Ebit TTM 226.92 % 88.99 % 11.1 % 82.66 % -6.48 % -46.15 %
EBIT Per Revenue TTM -213.03 % 36.48 % 10.48 % 17.88 % 15.62 % 9.12 %
Cash Flow To Debt Ratio TTM -29.08 % 39.73 % 14.18 % - 9.55 % 13.42 %
Receivables Turnover TTM 0.88 6.45 5.71 5.27 4.33 3.94
Payables Turnover TTM 2.7 6.63 3.53 1.25 3.48 6.47
Inventory Turnover TTM 1.64 1.14 1.3 3.09 2.1 2.27
Fixed Asset Turnover TTM 36.3 % 260.52 % 211.62 % 604.62 % 274.84 % 518.04 %
Asset Turnover TTM 12.83 % 62.94 % 27.2 % 33.71 % 39.43 % 33.55 %
Operating Cash Flow Per Share TTM -1.11 5.97 495.38 - 1.57 1.94
Free Cash Flow Per Share TTM -1.23 4.62 272.75 - 1.14 1.58
Cash Per Share TTM 3.92 % 345.55 % 51262.93 % 5.72 % 199.29 % 84.74 %
Operating Cash Flow Sales Ratio TTM -226.26 % 30.49 % 17.61 % - 10.92 % 15.17 %
Free Cash Flow Operating Cash Flow Ratio TTM 110.58 % 77.37 % 55.06 % - 72.53 % 81.65 %
Cash Flow Coverage Ratios TTM -29.08 % 39.73 % 14.18 % - 9.55 % 13.42 %
Price To Free Cash Flows Ratio TTM -10.28 39.53 16.05 - 16.56 7.65
Price To Operating Cash Flows Ratio TTM -10.52 30.75 4.39 - 12.01 6.24
Price Cash Flow Ratio TTM -10.52 30.75 4.39 - 12.01 6.24
Income Statement (TTM)
ALVO ZTS TAK HLN TEVA VTRS
Revenue $0.09B $8.54B $4263.76B $11.3B $15.85B $15.38B
Gross Profit $-0.07B $5.83B $2321.31B $6.96B $7.65B $6.57B
Gross Profit Ratio -75.93% 68.28% 54.44% 61.6% 48.25% 42.7%
EBITDA $-0.33B $3.56B $1254.52B $2.81B $4.27B $4.73B
Net Income $-0.55B $2.34B $144.07B $1.05B $-0.56B $0.05B
EPS Diluted -2.43 5.07 91.16 0.11 -0.5 0.05
Balance Sheet (MRQ)
ALVO ZTS TAK HLN TEVA VTRS
Long Term Debt $1.03B $6.56B $4476.5B $8.8B $18.48B $16.19B
Total Liabilities $1.88B $9.3B $7834.79B $17.33B $35.35B $27.22B
Total Equity $-0.93B $4.99B $7274.01B $16.73B $8.13B $20.47B
Total Investments $0.02B $0.02B $683.22B $0.07B $0.01B $1.23B
Total Debt $1.08B $6.8B $5463.39B $9.46B $20.15B $18.38B
Total Assets $0.95B $14.29B $15108.79B $34.06B $43.48B $47.69B
Cash Flow Statement (TTM)
ALVO ZTS TAK HLN TEVA VTRS
Net Income $-0.55B $2.34B $144.07B $1.05B $-0.62B $0.05B
Inventory $-0.01B $-0.36B $-115.74B $-0.13B $-0.15B $-0.61B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $-0.58B
Operating Cash Flow $-0.31B $2.35B $640.32B $1.72B $1.37B $2.8B
Capital Expenditure $-0.05B $-0.73B $-480.73B $-0.34B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 6.08
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.22
ALIM Alimera Sciences, Inc. 5.53
ALVOW Alvotech 2.5
AMPH Amphastar Pharmaceuticals, Inc. 48.74
AMRX Amneal Pharmaceuticals, Inc. 8.66
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 63.75
AQST Aquestive Therapeutics, Inc. 4.53
ASRT Assertio Holdings, Inc. 1.18
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 15.17
AYTU Aytu BioPharma, Inc. 2.5
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ALVO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.01 44.72
VEU Vanguard FTSE All-World ex-US Index Fund 0 61.68
VT Vanguard Total World Stock Index Fund 0 117.54
VXUS Vanguard Total Intl Stock Idx Fund 0 63.37
SCHE Schwab Emerging Markets Equity ETF 0.0129281 27.2
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 69.87
DWAS Invesco DWA SmallCap Momentum ETF 0.199 92.31
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.12 26.61
SPAK Defiance Next Gen SPAC Derived ETF 0.14 14.63
VTSNX Vanguard Total Intl Stock Idx Fund 0 136.29
STXK Ea Series Trust - Strive 2000 ETF 0.04 30.979
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 38.37
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.01 37.28
VTIAX Vanguard Total International Stock Index Fd Admiral 0 34.08
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 41.63
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.01 94.29
VTWIX Vanguard Total World Stock Index I 0 239.99
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 136.32
Unlock